Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Dominari Holdings Inc (DOMH)

NASDAQ
Currency in USD
Disclaimer
2.7900
+0.0800(+2.95%)
Closed

DOMH Comments

Scam Master Anthony Hayes continues on in his Scheming Immoral, Unethical, Cheating Ways as he continues Milking the funds Out..., Misappropriating, Diverting & Stealing The Investing Shareholders Fund$ going on a full Decade. Where is the SEC to shut him down???
Hasn't Anthony Hayes stolen enough already? -99.99% since becoming CEO
Do you see anyway our for this stock other than reverse split ?
now is best time to buy soon will jump wach and see
this guy is a fraud
Were looking good 4 this week Up Up we go!!!!!
What is the forecast for this stock
if anyone wants say something interesting: https://www.reddit.com/r/AIKI_stock/hot/
like to say that I love eating spam samwhickers wit sum mustard
why it looks to me head and shoulder
Bought @ 1,695
Will this stock back above 2$ again ?
I think it will, and hopefully soon...
What is the forecast for the stock now?
fruad ceo Hayees same plan what he was  doing since 5 years looting investor money once it go up
thank God...sold at 2.35
you missed the ax. catch ya next time lol
Will this hit $3 today?
Probably next week
next tp 2.75
Rocket go go go !!
dont believe this poor management
Super Bullish!!!
+3$ EOW!!!!
Target 3,30 and above this will fly!
What is today's target?
To the moon
What is today's target?
How about a little rally?
AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications PR Newswire NEW YORK , Jan. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applications.  The technology is covered by four patent applications already on file with the United States Patent and Trademark Office.
Hope it will go up a little more; just got in.
Anyone?
AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications PR Newswire NEW YORK , Jan. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applications.  The technology is covered by four patent applications already on file with the United States Patent and Trademark Office.
Any reason why pre mkt volume is high? Cheers.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.